Merck-backed Ebola vaccine moves towards clinical manufacturing

Hilleman Laboratories will manufacture an investigational Bundibugyo Ebola vaccine for clinical trials, as the DRC outbreak drives renewed focus on rapid vaccine development and scalable manufacturing